In a previous report we described the isolation and structural determination of five non-symmetrical dimers of 1,8-dihydroxynaphthalene from the endophytic fungus Edenia sp.: preussomerin EG 1 (1), palmarumycin CP 2 (2), palmarumycin CP 17 (3), palmarumycin CP 18 (4), and CJ-12,371 (5). We also characterized their specificity and strong activity against Leishmania donovani in this previous study. With the combined goal of scaling-up the production of these promising anti-parasitic agents as well as studying the structures and biological properties of minor analogs, we proceeded to perform a new large-scale cultivation using potato dextrose broth. Indeed, from the extract of this culture, we isolated the five previously reported compounds above (1-5) in addition to three newly isolated compounds: palmarumycin CP 19 (6), a new compound, and preussomerin EG 2 (7) and 5-methylochracin (8), both previously known metabolites from other studies. Compounds 6 and 8 showed moderate but selective activity against L. donovani (11.6 and 33.4 µM, respectively), while compound 7 was inactive in all bioassays. Finally, all of the isolated compounds were evaluated for cytotoxicity to MCF-7 cells and compounds 6-8 were also evaluated for activity to the Vero cell line. Compounds 1, 2, and 5 showed moderate activity to MCF-7 cancer cells (23.5, 25.8 and 18.3 µM, respectively) and none of the newly reported compounds (6-8) showed a marked cytotoxicity to Vero cells at 10 µg/mL.
INTRODUCTION
The palmarumycins and preussomerins are two families of pentacyclic compounds which are based on the linkage of two 1,8-dihydroxynaphthalene units that possess different oxidation stages. The palmarumicyns are the largest of these two families, and have been isolated from Coniothyrium species [Krohm et al., 1994a [Krohm et al., ,b, 1997 , Sphaeropsidales sp. , Decaisnella thyridioides [Jiao et al., 2006] , Microsphaeropsis sp. [Dai et al., 2007] , and others. This group of pentacyclic metabolites possesses antibacterial, antifungal, herbicidal and antiparasitic activities [Krohm et al., 1994a [Krohm et al., ,b, 1997 Ragot et al., 1999 , Barret et al., 2002 , Jiao et al., 2006 Martinez-Luis et al., 2008] . In recent years, their anticarcinogenic potential has been studied because they possess an uncommon mechanism of action which involves the thioredoxin-thioredoxin reductase system [Wipf et al., 2004 [Wipf et al., , 2005 Powis et al., 2006] . The preussomerins are also fungal metabolites and have been isolated from Preussia isomera [Weber et al., 1990 [Weber et al., , 1991 , Harmonema dermatoides [Polishook et al., 1993] , Sporormiella vexans [Soman et al., 1999] , Microsphaeropsis sp. BCC 3050 [Seephonkai et al., 2002] , Xilaria sp. [Isaka et al., 2000] , Edenia gomezpompae [Macias-Ruvalcaba et al., 2008] , as well as other species. These hexacyclic natural products have potentially useful properties as antibacterial, antifungal, anticarcinogenic and antiparasitic agents [Weber et al., 1990 [Weber et al., , 1991 Polishook et al., 1993; Soman et al., 1999; Isaka et al., 2000; Seephonkai et al., 2002; Macias-Ruvalcaba et al., 2008; Dong et al., 2008] . Since their discovery in 1969, these two families of unique natural products have been the subject of a number of interesting investigations of their synthesis and biosynthesis [Ragot et al., 1999; Barret et al., 2002; Weerapreeyakul et al., 2007] .
As a part of the ongoing research activities of the Panamanian International Cooperative Biodiversity Group (ICBG) program [Kursar et al., 2007 , we have recently focused our investigations on the discovery of new antiparasitic agents from endophytic fungi [Jimenez-Romero et al., 2008 , Martinez-Luis et al., 2008 . In this paper we describe the isolation, structural elucidation and biological activity of three additional naphthalene-type compounds from the endophytic fungus Edenia sp.
EXPERIMENTAL

General Experimental Procedures
Melting point measurements were carried out on an Electrothermal apparatus and are uncorrected. Optical rotations were measured with a Rudolf Research Analytical Autopol III 6971 automatic polarimeter. IR spectra were recorded on a Perkin-Elmer FT-IR RXI spectrophotometer. NMR spectra including COSY, NOESY, HMBC and HMQC experiments were recorded in CDCl 3 on a Bruker Avance 300 MHz spectrometer at 300 MHz ( 1 H) or 75 MHz ( 13 C) NMR, using TMS as an internal chemical shift reference. APCI-HR-MS were acquired on a JEOL LC-mate mass spectrometer (INDICASAT). HPLC was carried out on a Waters LC system, including a 600 pump and a 996 photodiode array detector, and YMC-Pack SIL (150-10 mm) NP-HPLC column. Column chromatography used silica gel 60 (70-230 mesh, Merck) and TLC (analytical and preparative) was performed on precoated silica gel 60 F254 plates (Merck). All solvents were HPLC grade and were used without further purification.
Fungal Material
The fungus Edenia sp. was isolated from mature leafs of Petrea volubilis L., collected in Coiba National Park, Veraguas, Panama, in 2004 by Alicia Ibañez (STRI, Panama City). Identification of the fungi was based upon the DNA sequence of the nuclear ribosomal internal transcribed spacer region and the first 600 bp of the nuclear ribosomal large subunit by Elizabeth Arnold of the University at Arizona. A voucher was deposited at the Smithsonian Tropical Research Institute (voucher number 349B1). Ten 1 L Erlenmeyer flasks, each containing 0.5 L of Potate Dextrose Broth (Scharlau Chemie), were individually inoculated with a 1 cm 2 agar plug taken from a stock culture of Edenia sp. and placed on an orbital shaker at 150 rpm at 28 ºC for 15 days.
Extraction and Isolation
After incubation, all flask contents were combined and filtered. The combined culture filtrate (4.5 L) was extracted exhaustively with EtOAc. The organic phase concentrated in vacuum to give a dark brown solid (1.4 g). The extract was subjected to Si gel (400 g) open column chromatography eluting with a stepwise gradient of 100% hexanes to 100% EtOAc to 1:1 EtOAc-MeOH to yield 16 major fractions (F1-F16). From fraction F2, eluted with hexanes-EtOAc (8:2), a colorless solid precipitated which was purified by recrystallization from MeOH to yield preussomerin EG1 (1 mg, 1). Fraction F3 eluted with hexanes-EtOAc (7:3), was purified by NP-HPLC (YMC-Pack SIL 150 x 10 mm NP-HPLC column, 85% hexanes / 15% EtOAc, 254 nm, 0.6 mL/min) to afford pure palmarumycin CP 2 (3 mg, 2) as a colorless solid. Similarly, a co-lorless solid precipitated from fraction F4, eluted with hexanes-EtOAc (6:4), that was purified by recrystallization from MeOH to yield palmarumycin CP 17 (3 mg, 3). Compound 7 was obtained by RP-HPLC purification of fraction 5 by means of RP-HPLC (Xterra RP 18 column, 250 x 10 mm, 50% MeOH/ 50% H 2 O, 225 nm, 1.0 mL/min). Compound 8 was obtained by NP-HPLC purification of fraction 6 (YMC-Pack SIL 150 x 10 mm NP-HPLC column, 60% hexanes / 40% EtOAc, 254 nm, 0.6 mL/min). Fraction F7 (eluted with hexanes-EtOAc, 4:6) contained a reddish-brown solid (3 mg, 4), that was purified by YMC-Pack SIL 150 x 10 mm NP-HPLC column, 75% hexanes / 25% EtOAc, 254 nm, 0.6 mL/ min. Finally, from fraction 9, eluted with hexanes-EtOAc 3:7, CJ-12,371 (3 mg, 5) and Palmarumicyn CP 19 (2 mg, 6) were isolated by RP-HPLC (Xterra RP 18 column, 250 x 10 mm, 70% MeOH / 30% H 2 O, 225 nm, 0.7 mL/min).
Palmarumycin 3450, 3063, 1690, 1645, 1597, 1285; 1 H NMR (CDCl 3 , 300 MHz): δ: 11.70 (1H, s, OH-5), 7.65 (1 H, dd, J = 7.8, 1.0 Hz, H-5'), 7.40 (1H, dd, J = 7.8, 7.8 Hz, H-6'), 7.08 (1H, dd, J = 7.8, 1.0 Hz, H-7'), 7.03 (1H, d, J = 9.1 Hz, H-7), 6.93 (1H, d, J = 9.1 Hz, H-6), 4.71 (1H, s br, H-2'), 3.37 (1H, m, H-3b'), 3.36 (1H, m, H-3b), 3.01 (1H, dd, J = 2.5, 17.8 Hz, H-3a'), 2.90 (1H, ddd, J = 5.0, 13.0, 18.3, H-3a), 2.76 (1H, ddd, J = 1.5, 5.0, 13.0, H-2b), 2.58 (1H, s, OH-2'), 2.49 (1H, ddd, J = 5.0, 13.0, 13.0, H-2a);
13 C (CDCl 3 , 75 MHz): δ: 202.4 (C-4), 194.0 (C-4'), 157.8 (C-5), 151.2 (C-6'), 141.3 (C-8), 131.5 (C-6'), 131.2 (C4a'), 126.4 (C-7), 121.9 (C-7'), 121.2 (C-6), 120.8 (C-5'), 120.4 (C-8a), 119.7 (C-8a') 113.3 (C-4a), 94.4 (C-1'), 93.8 (C-1), 70.6 (C-2'), 41.8 (C-3'), 34.1 (C-3), 33.0 (C-2); APCI-MS m/z 367.0803 [M+H] + (calcd for C 20 H 15 O 7 , 367.0812). 
5-methylochracin, (-)-(3R)-3,4-dihydro-8-hydroxy-3,5-dimethylisocoumarin (8):
BIOASSAYS Antileishmanial Bioassay
In this bioassay, we employed axenically grown (cell free) amastigotes of L. donovani (LD-1S/MHOM/SD/00-strain 1S), the species responsible for the visceral and lethal form of the leishmania. The assay measures parasite growth and survival and employs PicoGreen. Samples for screening were originally tested in duplicate at a single concentration of 10 µg/mL. Results were expressed as percentage of parasite growth (% G) compared to control. Samples that showed 50% G or less were considered active and were then assayed at six concentrations (0.00032, 0.0016, 0.08, 0.4, 2, and 10 µg/ mL) to determine IC 50 values. Amphotericin B was used as a positive control with the typical IC 50 response of L. donovani to this drug is between 70 and 120 ng/µL [Calderon et al., 2006; Martinez-Luis et al., 2008] .
Chagas disease bioassays
Chagas disease bioassays were performed using a colorimetric method, the inhibition of parasite growth was assessed by the expression of the reporter gene for betagalactosidase (β-Gal) in the recombinant Tulahuen clone C4 of Trypanosoma cruzi. Assays were performed in triplicate on the amastigote, the intracellular form of the parasite infecting African green monkey kidney (Vero) cells, exposed during 120 h to different concentrations (10, 2 and 0.4 μg/mL) of the test compounds at 37°C under an atmosphere of 5% CO2/ 95% air. The resulting color from the cleavage of chlorophenol red-β-D-galactoside (CPRG) by β-Gal expressed by the parasite was measured at 570 nm. The concentration that inhibited 50% expression of β-Gal (IC50) was calculated by log regression of the obtained optical density values, and compared with the untreated controls. Nifurtimox was used as a positive control (IC 50 = 3-5 µg/mL) [Buckner et al., 1996; Sanchez et al., 2007] .
Malaria bioassays
The antiplasmodial activity was evaluated using a fluorometric method based on the detection of parasite DNA with the fluorochrome PicoGreen using a choroquine-resistant strain (Indocrina W2) of P. falciparum. The parasites were maintained in vitro by a modification of the method of Trager and Jensen (1976) , and we used chloroquine as a positive control (IC 50 = 80-100 nM) [Corbett et al., 2004; JimenezRomero et al., 2008] .
Cytotoxicity bioassays
The cytotoxic activity against MCF-7 (human breast cancer cell line) was performed following the standard protocol of the National Cancer Institute [Monks et al., 1991] .
Vero Cell Bioassay
Vero cells, derived from kidneys of the African green monkey, were adhered to 96-well plates and used to evaluate the toxicity of the compounds purified from Edenia sp. employing the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich, St. Louis, MO) method. After treatment with the test compound and 4 h incubation at 37 °C, cell viability was evaluated in an ELISA reader at 570 nm [Van de Loosdrecht et al., 1994; Sanchez et al., 2007; Jimenez-Romero et al., 2008] .
In all bioassays, the samples were evaluated using a maximum concentration of 10 µg/mL.
RESULTS AND DISCUSSION
The endophytic fungus Edenia sp. (mitosporic Ascomycota) was isolated from a mature leaf of Petrea volúbilis L (Verbenaceae) collected from the Coiba National Park in Panama. In this study, the same fungal strain was cultivated in small scale using four different culture broths [Modified malt extract (MME), Potato dextrose broth (PDB), Czapex Dox (CD), eight vegetables (8V)], and then the extracts of each medium were prepared by partitioning with Ethyl Acetate (EtOAc). The extracts were each tested for their anti-parasitic activity and the most active were those obtained from the MME and PDB cultures (Table 1) . Therefore, the fungus was grown in large scale (4.5 L) using PDB which yielded 1.4 g of crude extract.
The bioactive extract (IC 50 = 0.14 µg/ mL) was fractionated by gravity column chromatography to give 16 fractions (F1-F16). Compounds 1 and 2 were obtained by crystallization and RP-HPLC purifica- Figure  1 ) and 7-8 were identical to previously obtained [Martinez-Luis et al., 2008 and references cited therein; Macias-Ruvalcava et al., 2008; Okuno et al., 1986] . Compound 6 represents a new natural product. Compound 6 was isolated as a white powder. The molecular formula was determined as C 21 H 18 O 4 by APCI-HR-MS in positive ion mode which showed a protonated parent ion peak at m/z 335.1013 [M + H] + . The formula was consistent with the number of protons and carbons observed by NMR spectra. The 1 H NMR spectrum (Table 2 ) revealed the presence of three ABC spin systems: one corresponded to a 1,2,3 trisubstituted aromatic ring (δ H 7.40, dd, J = 7.8, 1.4 Hz, 7.35, brd, J = 7.8 Hz, and 6.99, dd, J = 7.8, 1.4 Hz, H-6) and two almost identical, which were consistent with a 1,8-disubstituted naphthalenyl aromatic ring (δ H 7.51, brd, J = 7.8 Hz, H-2' or H-7'; 7.43, dd, J = 8.3, 2.0 Hz, H-3' or H-6'; 6.93, dd, J = 7.3, 1.0 Hz, H-4' or H-5'; δ H 7.51, brd, J = 7.8 Hz, H-2' or H-7'; 7.43, dd, J = 8. (Table 2) , interpreted from multiplicity-edited HSQC data as eight quaternary, two methylene, ten methine, and one methyl carbons. This spectrum also possessed resonances for the characteristic carbons of an 1,8-dihydroxynaphthalene ring system [δ C 148.3 (C-1'); 109.7 (C-2'); 127.8 (C-3'); 120.8 (C-4'); 134.6 (C-4a'); 120.8 (C-5'); 127.8 (C-6'); 109.7 (C-7'); 148.2 (C-8'); 113.9 (C-8a')] as well as a resonance for a carbon of methoxyl group (δ C 54.6). The chemical shifts of the two carbons at δ C 148.3 and 148.2 were consistent with the placement of a dioxin bridge to C-1' and C-8' of the naphthalene core. Finally, the chemical shifts of the signals at δ C 156.6 were consistent with the positioning of a phenolic hydroxy group at C-5. This new natural product, given the trivial name palmarumycin CP 19 (6), has the same overall molecular arrangement as observed in CJ-12,372 with the variation occurring only in the nature of the substituent at C-4. In compound 6, C-4 is substituted with a methoxy group whereas in 5 C-4 bears a hydroxyl group. This assignment was confirmed by observation of the important HMBC correlation from OCH 3 → CH-4 (Figure 2) . Previously, the absolute stereochemestry at C-4 in CJ-12,371 was determinated as S-configuration by applying the CD exciton chirality method to its O-p-N,N-dimethylaminobenzoyl derivative [Sakemi et al., 1995] . As the compound 6 has one stereogenic center (as compound 5, each possible enantiomer has an equal but opposite optical rotation), with comparing the sign of their optical rotation we can deduce the absolute configuration at C4. The absolute configuration of the stereogenic center (C-4) of 6 was determined as S, because those both compounds gave the same signal (-) in their optical rotation. On the basis of these data, the structure of 6 was elucidated as 4(S)-methoxy-2,3-dihydro-2(H)-spiro[naphthalene-1(4H),2'-naphtho [1,8-de] This is the first report of 6 as a natural product, although Sakemi and co-workers reported in 1995 the semi-synthesis of 6 by means of reaction of CJ-12,371 (5) with CH 3 I and K 2 CO 3 in tetrahydrofuran at 60°C for 3 hours [Sakemi et al., 1995] .
Compounds 6-8 were tested for activity against three tropical disease parasites, L. donovani, T. cruzi and P. falciparum, and compounds 6 and 8 showed selective activity against Leishmania (Table 1) . Of the three additional compounds isolated in this study, compound 6 was the most active inhibitor of L. donovani amastigotes (IC 50 = 0.12 µM), but was still less active than the previously reported compounds 1-5. Finally, all of the isolated compounds were evaluated for cytotoxicity to MCF-7 cells and compounds 6-8 were also evaluated for activity to the Vero cell line. Compounds 1, 2, and 5 showed moderate activity to MCF-7 cancer cells (23.5, 25.8 and 18.3 µM, respectively) and none of the newly reported compounds (6-8) showed a marked cytotoxicity to Vero cells at 10 µg/mL (Tables 1 and 3). when C-4 bears a hydroxyl group, as with compound 5 (IC 50 = 8.4 µM) or a methoxyl group, as in compound 6 (IC 50 = 11.6 µM). This impact of structure on antileishmania activity is similar to the trend observed for anticancer activity, but in this latter case, the best activity is shown when C-4 has a hydroxyl group (IC 50 = 18.7 µM), and decreases when C-4 bears a carbonyl group (IC 50 = 25.8 µM), and is inactive when this position contains a methoxyl group.
CONCLUSIONS
Edenia sp. biosynthetically produces polyketides of the palmarumycin and preussomerin compound families that possess selective antiparasitic activity against L. donovani. Interestingly, Edenia sp. produces the same classes of compounds in all four media used in its cultivation, although the best yield and activity were observed in cultures made with PDB and MME. The quantity of compounds isolated from both media were very similar, so we can conclude that the type of growing medium may possibly not affect the yield of main bioactive metabolites produced by the fungus.
It is highly probable that CJ-12,371 (5) is the biogenetical precursor of palmarumicyn CP 19 (6) in that a simple methylation of the C-4 hydroxyl group by an appropriate alkylating agent such as S-adenosylmethionine or dimethylallyl diphosphate explains its metabolic origin. Finally, the metabolites from Edenia sp. appear to be promising drug leads against the tropical parasite L. donovani.
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